Skip to content

CBD: all studies

Page 26 of 38: studies 251 to 260 of 375, newest first. Back to the CBD overview

Research

How low can you go? Intraoperative microdosing of indocyanine green for fluorescence cholangiography during laparoscopic cholecystectomy.

Surgical endoscopy October 1, 2025 Ryan C Broderick, Graham J Spurzem, Ana Garcia Cabrera et al.

Fluorescence cholangiography (FC) with indocyanine green (ICG) enables real-time intraoperative visualization of extrahepatic biliary anatomy during laparoscopic cholecystectomy (LC). There is no consensus on the optimal ICG dose or timing of administration for LC. The goal of this study was to implement a simple intraoperative low-dose ("microdose") ICG protocol that facilitates non-inferior...

DOI: 10.1007/s00464-025-12057-w (opens in new tab) Full text (opens in new tab) Fluorescence cholangiography Indocyanine green Laparoscopic cholecystectomy Microdose +1

Cannabinoid use generalizes stress responses by altering the astrocyte plasticity through extracellular matrix signaling in the nucleus accumbens core.

Research Square August 21, 2025 Ritchy Hodebourg, Lillian Duncan, Eric Dereschewitz et al. preprint

The rising legal acceptance of cannabis and the high comorbidity between cannabis use disorder (CUD) and post-traumatic stress disorder (PTSD) highlight the importance of understanding how stress and cannabis influence the brain. We recently discovered that cannabis use promotes two PTSD-like symptoms: avoidance coping behaviors and the generalization of stress-coping responses to a neutral...

Cannabis and suicide risk in first-episode psychosis: Mechanisms, interactions, and intervention strategies.

Asian Journal of Psychiatry July 10, 2025 Valerio Ricci, Alessandro Sarni, Marialuiga Barresi et al.

Cannabis use represents a significant risk factor for both psychotic disorders and suicidal behaviors, with growing evidence suggesting complex interactions between these variables. This systematic review examines the relationship between cannabis use and suicide risk in first-episode psychosis (FEP) patients, and explores underlying mechanisms, moderating factors, and intervention strategies....

Inflammatory state moderates response to cannabis on negative affect and sleep quality in individuals with anxiety

Frontiers in Behavioral Neuroscience July 1, 2025 Richard G. Hunter, Annelise Madison, Jonathon K. Lisano et al.

Introduction Inflammation has been implicated as an underlying pathology in negative affect and sleep disruption. Cannabinoids like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have demonstrated anti-inflammatory properties. This study aimed to assess if cannabis use altered cytokine concentration and whether inflammatory status moderated the influence of 4 weeks of cannabis use on...

Receptor-enriched analysis of functional connectivity (REACT) for understanding cannabinoid neuropsychopharmacology

bioRxiv (Cold Spring Harbor Laboratory) June 5, 2025 Ekaterina Shatalina, Natalie Ertl, Kat Petrilli et al. 1 citation preprint

Abstract Background Cannabis is one of the most widely used psychoactive substances in the world and is increasingly investigated as a treatment for neuropsychiatric conditions. Cannabis contains delta-9-tetrahydrocannabinol (THC), which is thought to underlie its main psychoactive effects, and cannabidiol (CBD), which has been proposed to modulate the effects of THC on the brain. Both have...

DOI: 10.1101/2025.06.02.657387 (opens in new tab) Full text (opens in new tab) Neuropsychopharmacology Cannabinoid receptor Functional connectivity Endocannabinoid system +2

Infant Death due to Cannabis Ingestion.

Drug Testing and Analysis May 21, 2025 Donata Favretto, Antonello Cirnelli, Roberto Pertile et al. 2 citations

A child died in the emergency room of a local hospital a few hours after ingesting a substance the color of cork and the consistency of earth. At home, a modest amount of resinous substance was found. At the hospital, the child exhibited alterations in walking, balance, and consciousness. Intubation was needed for the onset of dyspnea, so fentanyl and ketamine were administered during the...

Effects of different methods of cannabis use on cognition and blood THC: A systematic review.

Progress in Neuro-Psychopharmacology and Biological Psychiatry May 1, 2025 Danial Behzad, S. Patel, R. Besa et al.

Novel methods of cannabis use are becoming popular, but the differential impact of these new methods on cognition have not been widely studied. Further, the impact of cannabis on cognition is mediated by delta-9-tetrahydrocannabinol (THC), but few studies have directly compared the pharmacokinetics of different methods. This systematic review (PROSPERO, CRD42023442731) was conducted to...

The use of cannabinoid therapy in treatment-refractory isolated REM sleep behavior disorder: a case report

Journal of Clinical Sleep Medicine March 25, 2025 Sahej Samra, Hrayr Attarian, R. Malkani

Current treatments for rapid eye movement sleep behavior disorder are not always effective and can lead to dose-limited adverse events, and new treatments are needed for this condition. We present a case of a patient with treatment-refractory isolated rapid eye movement sleep behavior disorder who had a dramatic and sustained improvement in dream enactment behaviors using oral tinctures...

Emerging medications and pharmacological treatment approaches for substance use disorders.

Pharmacology, Biochemistry, and Behavior March 1, 2025 Joel S Raymond, Alexander G Athanasopoulos, Connie J Badolato et al. 7 citations

Medications to treat substance use disorders (SUDs) remain suboptimal or, in the case of stimulants and cannabis, non-existent. Many factors have contributed to this paucity, including the biological complexity of addiction, regulatory challenges, and a historical lack of enthusiasm among pharmaceutical companies to commit resources to this disease space. Despite these headwinds, the recent...

Investigating the Relationship Between Cannabis Expectancies and Anxiety, Depression, and Pain Responses After Acute Flower and Edible Cannabis Use.

Cannabis and Cannabinoid Research February 1, 2025 Margy Y. Chen, Emily B Kramer, Laurel P Gibson et al.

Objective: Cannabis has been touted for a host of pharmacological and therapeutic effects and users commonly report reduced symptoms of physical and mental health conditions, including anxiety, depression, and chronic pain. While there is existing empirical evidence supporting these effects of cannabis use, little is known about the extent to which these effects result from pharmacological...